Compare · MDLN vs SNWV
MDLN vs SNWV
Side-by-side comparison of Medline Inc. (MDLN) and SANUWAVE Health Inc. (SNWV): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both MDLN and SNWV operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- MDLN is the larger of the two at $48.08B, about 1081.1x SNWV ($44.5M).
- Over the past year, MDLN is down 11.8% and SNWV is down 84.0% - MDLN leads by 72.2 points.
- MDLN has been more active in the news (7 items in the past 4 weeks vs 5 for SNWV).
- MDLN has more recent analyst coverage (25 ratings vs 2 for SNWV).
PerformanceMDLN-11.77%SNWV-84.56%
2025-12-17+0.00%2026-10-16
- Company
- Medline Inc.
- SANUWAVE Health Inc.
- Price
- $35.95-1.74%
- $5.00-1.57%
- Market cap
- $48.08B
- $44.5M
- 1M return
- +11.97%
- +20.48%
- 1Y return
- -11.77%
- -84.02%
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2025
- News (4w)
- 7
- 5
- Recent ratings
- 25
- 2
Latest MDLN
- SEC Form 8-K filed by Medline Inc.
- Medline to build Midwestern network with new 800,000-square-foot facility in Van Buren Township, Mich.
- SEC Form 4 filed by Medline Inc.
- Medline launches enhanced TrackPoint™ to simplify inventory management for post-acute care
- SEC Form 4 filed by Medline Inc.
- MEDLINE INC. MDLN INVESTORS: Contact Kirby McInerney LLP About the Firm’s Securities Investigation Following 12.8% Share Drop
- Medline to report third quarter 2026 results on November 4, 2026
- INVESTOR ACTION NOTICE: Moore Law PLLC Encourages Investors in Medline Inc. to Contact Law Firm
- Medline announces participation in the Morgan Stanley 24th Annual Global Healthcare Conference
- SEC Form 4 filed by Chief Executive Officer Boyle James M
Latest SNWV
- SEC Form 4 filed by Director Tyler James
- SEC Form 4 filed by Chief Executive Officer Frank Morgan C.
- SEC Form 4 filed by Director Bazar Gregory Matthew
- SEC Form 4 filed by Director Blizard Jeffrey
- SEC Form 4 filed by Director Miller Ian D.
- SANUWAVE Health Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
- SANUWAVE Health Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Sanuwave Announces Q2 FY2026 Financial Results
- SEC Form 10-Q filed by SANUWAVE Health Inc.
- Sanuwave Will Host a Conference Call on August 7, 2026 at 8:30 AM (ET) to Present Q2 2026 Financial Results